Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
Fintel on MSN14h
Ladenburg Thalmann Downgrades Zynex (ZYXI)Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...
ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...
Ladenburg downgraded Zynex (ZYXI) to Neutral from Buy without a price target saying the company continues to adjust operationally amid revenue ...
Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.
Fintel on MSN14d
Ladenburg Thalmann Upgrades Spire (SR)Fintel reports that on February 26, 2025, Ladenburg Thalmann upgraded their outlook for Spire (NYSE:SR) from Sell to Buy.
On Tuesday, Portland General Electric Company (NYSE:POR), currently trading at $41.64 and near its 52-week low, experienced a shift in its stock rating, as Ladenburg Thalmann analysts downgraded the ...
Ladenburg Thalmann is an industry-standard asset manager, leading to an Average Parent Pillar rating. Portfolio management turnover has been minimal at the firm over the past five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback